Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $23.00 USD
Change Today -0.25 / -1.08%
Volume 459.2K
SGNT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - SAGENT PHARMACEUTICALS INC (SGNT)

Sagent Pharmaceuticals, Inc. to Report Q4, 2014 on Feb 19, 2015
CapIQ 02/19/2015 2:00 PM ET
Sagent Pharmaceuticals, Inc. to Report Q3, 2014 on Nov 04, 2014
CapIQ 02/19/2015 2:00 PM ET
Sagent Pharmaceuticals, Inc. to Report Q2, 2014 on Jul 30, 2014
CapIQ 02/19/2015 2:00 PM ET

2013 revenues at Sagent Pharmaceuticals, Inc. totaled $244.8M USD, while annual earnings equaled $0.68 per share.

Quarterly Earnings & Estimates - SAGENT PHARMACEUTICALS INC (SGNT)

Actuals vs. Estimates for SAGENT PHARMACEUTICALS INC SGNT

Sagent Pharmaceuticals, Inc.'s Quarterly Earnings

Sagent Pharmaceuticals, Inc. reported 2nd quarter 2014 earnings of $0.09 per share on 08/1/2014.

Annual Earnings & Estimates - SAGENT PHARMACEUTICALS INC (SGNT)

Actuals vs. Estimates for SAGENT PHARMACEUTICALS INC SGNT

Sagent Pharmaceuticals, Inc.'s Annual Earnings

Sagent Pharmaceuticals, Inc. reported annual 2013 earnings of $0.68 per share on 02/13/2014.

Quarterly Revenues - SAGENT PHARMACEUTICALS INC (SGNT)

Actuals vs. Estimates for SAGENT PHARMACEUTICALS INC SGNT

Sagent Pharmaceuticals, Inc.'s Quarterly Revenues

Sagent Pharmaceuticals, Inc. had 2nd quarter 2014 revenues of $69.2M USD. This bettered the $67.2M USD consensus of the 7 analysts covering the company. This was 16.1% above the prior year's 2nd quarter results.

Annual Revenues - SAGENT PHARMACEUTICALS INC (SGNT)

Actuals vs. Estimates for SAGENT PHARMACEUTICALS INC SGNT

Sagent Pharmaceuticals, Inc.'s Annual Revenues

Sagent Pharmaceuticals, Inc. had revenues for the full year 2013 of $244.8M USD. This was 33.3% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGNT:US $23.00 USD -0.25

SGNT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Momenta Pharmaceuticals Inc $15.21 USD +0.01
Pernix Therapeutics Holdings Inc $10.58 USD -0.11
Pfizer Ltd/India 2,217 INR 0.00
SciClone Pharmaceuticals Inc $9.28 USD +0.42
Sucampo Pharmaceuticals Inc $15.73 USD +0.17
View Industry Companies
 

Industry Analysis

SGNT

Industry Average

Valuation SGNT Industry Range
Price/Earnings 19.1x
Price/Sales 2.6x
Price/Book 2.7x
Price/Cash Flow 18.7x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAGENT PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.